Capmatinib Completed Phase 1 Trials for Tumors, Solid Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01324479Study of INC280 in Patients With c-MET Dependent Advanced Solid Tumors